Cheng Gong Zhu
Amministratore Delegato presso Kaifeng Pharmaceutical (Group) Co., Ltd.
Provenienza dei contatti di primo grado di Cheng Gong Zhu
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Kaifeng Pharmaceutical (Group) Co., Ltd.
 Kaifeng Pharmaceutical (Group) Co., Ltd. Pharmaceuticals: MajorHealth Technology Kaifeng Pharmaceutical (Group) Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include injection, tablets, capsules, granules, eye drops, ointments, and pharmaceutical raw materials. The company was founded on May 17, 1949 and is is headquartered in Kaifeng, China.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Furen Medicines Group Co., Ltd.
 Furen Medicines Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Furen Medicines Group Co. Ltd. engages in producing and marketing of pharmaceutical product. Its product include antibiotical, analgesics, antimalaria, anticancer and antihypertensive. The company was founded in 1997 and is headquartered in Zhengzhou, China.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Shenyang Pharmaceutical University
6
| College/University | Other Consumer Services | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Cheng Gong Zhu tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| FUREN GROUP PHARMACEUTICAL CO.,LTD. | Biotechnology | Chief Executive Officer Chief Executive Officer Chairman Chairman | |
| Cheung Kong Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Kyoto Pharmaceutical University | College/University | Doctorate Degree | |
| Santen Pharmaceutical (China) Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Sinotau Pharmaceuticals Group
 Sinotau Pharmaceuticals Group Pharmaceuticals: MajorHealth Technology Sinotau Pharmaceuticals Group is a Chinese pharmaceutical company founded in 2005 that focuses on becoming an overall solution provider in the field of neurological degenerative lesions. The company is based in Beijing, China, and has subsidiaries in China. The company offers a range of products and services, including nuclear medicine, radioactive drug development, high-quality production, and clinical academic promotion. The company has a drug research and development technology platform and monoclonal antibody research and development drug technology platform, supplemented by generic drug research and development, production, and sales. The company also offers targeted drugs, precise diagnosis, and precision therapy drugs guided by research, development, and commercial molecular images. | Pharmaceuticals: Major | President | |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
| Guangdong Xiantong Molecular Imaging Technology Co. Ltd. | Director/Board Member | ||
| SINO BIOLOGICAL,INC. | Pharmaceuticals: Major | Director/Board Member | |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Biotechnology | Director/Board Member | |
| Suzhou Keyue Biotech Co. Ltd. | Director/Board Member | ||
Suzhou Cure Genetics Co., Ltd.
 Suzhou Cure Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Cure Genetics Co., Ltd. is a biotechnology company based in Suzhou, China. The Chinese company specializes in developing gene and cell therapy for tumors and genetic diseases. | Pharmaceuticals: Major | Director/Board Member | |
Beijing Sinotau Pharmaceutical Technology Co., Ltd.
 Beijing Sinotau Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sinotau Pharmaceuticals Group, Beijing Sinotau Pharmaceutical Technology Co., Ltd. is a company founded in 2005 that engages in research & development, manufacture and promotion of radiopharmaceuticals and biological antibody drugs. The company is based in Beijing, China. | Miscellaneous Commercial Services | President | |
| Suzhou Qiyuan Equity Investment Mgmt Partnership Enterprise LP | Corporate Officer/Principal | ||
| Asia Baokang Pharmaceutical Consulting Beijing Co. Ltd. | Corporate Officer/Principal | ||
| Jacobio Hk Pharmaceuticals Co. Ltd. | Director/Board Member | ||
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| ABBISKO CAYMAN LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| SINOCELLTECH GROUP LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| NovoTek Therapeutics, Inc. | Chief Executive Officer | ||
NovoTek Pharmaceuticals Ltd.
 NovoTek Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Yifan Pharmaceutical Co., Ltd., NovoTek Pharmaceuticals Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Hong Kong, Hong Kong. The company was founded by Ju Bo Liu. Ju Bo Liu has been the CEO since incorporation. NovoTek Pharmaceuticals was acquired by Yifan International Pharmaceutical Co., Ltd. from Merrylake International Ltd. on January 25, 2018 for $20.60 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| Novotek Medicinal Technology Development Co. Ltd. | Chief Executive Officer | ||
| Huayuanlong Medicinal Technology Development Co. Ltd. | General Counsel | ||
| University of Toronto | College/University | Doctorate Degree | |
| SCIGEN LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Beijing Novotek Medicinal Technology Development Co. Ltd. | Chief Executive Officer | ||
Itabmed Co., Ltd.
 Itabmed Co., Ltd. BiotechnologyHealth Technology ITabMed Co., Ltd. is a Chinese clinical-stage biotech company that focuses on the discovery and development of immunotherapy products to treat cancer. The company is based in Shanghai, China. ITabMed Co. was founded in 2020 by Xiaoqiang Yan, who has been the CEO since 2020. | Biotechnology | Director/Board Member | |
| BIOTON S.A. | Pharmaceuticals: Major | Director/Board Member | |
| HEALTH AND HAPPINESS (H&H) INTERNATIONAL HOLDINGS LIMITED | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
| Sun Yat-Sen University | College/University | Masters Business Admin | |
Henan Furentang Pharmaceutical Co. Ltd.
 Henan Furentang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FUREN Group Pharmaceutical Co., Ltd., Henan Furentang Pharmaceutical Co. Ltd. manufactures and sells pharmaceutical products. The company is based in Zhengzhou, China. The CEO of the Chinese company is Hai Yun. Henan Furentang Pharmaceutical Co. was acquired by FUREN Group Pharmaceutical Co., Ltd. from Henan Furen Medicines Group Co. Ltd. on April 25, 2005 for $20.82 million. | Pharmaceuticals: Major | Chairman | |
Henan Furen Medicines Group Co. Ltd.
 Henan Furen Medicines Group Co. Ltd. BiotechnologyHealth Technology Henan Furen Medicines Group Co. Ltd. is a Chinese pharmaceutical company that manufactures and distributes pharmaceutical drugs. The private company is based in Zhengzhou, China. and has subsidiaries in China. | Biotechnology | Chairman | |
| Jilin University | College/University | Graduate Degree | |
| TIBET WEIXINKANG MEDICINE CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Xiamen LP Pharmaceutical Co., Ltd.
 Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Cina | 29 |
| Hong Kong | 4 |
| Giappone | 2 |
| Isole Cayman | 2 |
| Canada | 2 |
Settori
| Health Technology | 17 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Finance | 2 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 35 |
| Chief Executive Officer | 8 |
| Chairman | 8 |
| Corporate Officer/Principal | 6 |
| Undergraduate Degree | 5 |
Contatti più connessi
| Insiders | |
|---|---|
| Yan Min Tang | 17 |
| Ju Bo Liu | 11 |
| Wen Yu Zhu | 4 |
| Zhao Peng Hu | 4 |
| Ri Gao Sun | 3 |
| Wen Liang Zhu | 3 |
| Zhi Hua Jiang | 3 |
| Wen Chen Zhu | 3 |
| Yong Zhang | 3 |
| San Ming Li | 2 |
| Qi Zhi Liu | 1 |
| Zhong Xue Li | 1 |
| Hai Chao Zhang | 1 |
| Jing Sheng Zhu | 1 |
| Qiang Meng | 1 |
- Borsa valori
- Insiders
- Cheng Gong Zhu
- Connessioni Società
